๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pancreatic Cancer Stage III

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328Phase 3333 sites๐Ÿ“ Gilbert๐Ÿ“ Gilbert๐Ÿ“ Peoria NRG Oncology ยท Tests: Biopsy Procedure, Biospecimen Collection, Capecitabine, Computed Tomography, Dose-escalated Radiation Therapy Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer NCT06454383Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Cholestyramine, Computed Tomography, Diagnostic Imaging, Gemcitabine CREO - Microwave Ablation Feasibility Study NCT07817147NA7 sites๐Ÿ“ Gilbert๐Ÿ“ Los Angeles๐Ÿ“ Chicago Banner Health ยท Tests: EUS-Guided MWA Device Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders NCT00830557n/a3 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: medical chart review, survey administration, biospecimen collection The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer NCT04406831n/a1 site๐Ÿ“ Norwalk Nuvance Health ยท Tests: Blood draw Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma NCT07619521Phase 1, Phase 21 site๐Ÿ“ Pittsburgh National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test, Multigated Acquisition Scan, Selumetinib Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial NCT06593431Phase 34 sites๐Ÿ“ Camden๐Ÿ“ Voorhees Township๐Ÿ“ Dallas M.D. Anderson Cancer Center ยท Tests: Consolidative Radiation Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy NCT07823049Phase 348 sites๐Ÿ“ Shanghai๐Ÿ“ Beijing๐Ÿ“ Beijing Evopoint Biosciences Inc. ยท Tests: XNW28012 for injection, XNW28012 Mimetic for Injection Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Stanford Anusha Kalbasi ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer NCT07238283Phase 31 site๐Ÿ“ Beijing Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate, nab-paclitaxel; gemcitaโ€ฆ Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors NCT05687123Phase 110 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Orange National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Positron Emission Toโ€ฆ An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. NCT05884255Phase 32 sites๐Ÿ“ Shanghai๐Ÿ“ Tianjin Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Lutetium (177Lu) Oxodotreotide Injection๏ผ›long-acting Octreotide, long-acting Octreotide Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX NCT07044453Phase 2, Phase 31 site๐Ÿ“ Rouen University Hospital, Rouen ยท Tests: Gem/Nabpaclitaxel infusion, mFOLFIRINOX infusion A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer NCT06361888Phase 2, Phase 352 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Beijing Hutchmed ยท Tests: Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine, Nab-paclitaxel Plus Gemcitabine, Surufatinib wโ€ฆ Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations NCT06998940Phase 3274 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage SWOG Cancer Research Network ยท Tests: Biospecimen Collection, Computed Tomography, Fluorouracil, Gemcitabine, Irinotecan Targeted Pathway Inhibition in Patients With Pancreatic Cancer NCT04005690EARLY Phase 11 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Cobimetinib, Olaparib, Onvansertib, Azenosertib, Saruparib Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer NCT04969731Phase 31 site๐Ÿ“ Seoul GC Cell Corporation ยท Tests: Immuncell-LC, Gemcitabine A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations NCT06906562Phase 2109 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Montgomery Sameek Roychowdhury ยท Tests: Pemigatinib, Computed Tomography (CT), Magnetic Resonance Imaging, Optical Coherence Tomography, Bone Scan OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma NCT07089940EARLY Phase 11 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Myc Inhibitor OMO-103 HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer NCT07232875Phase 31 site๐Ÿ“ Shanghai Jiangsu HengRui Medicine Co., Ltd. ยท Tests: HRS-4642 + AG, HRS-4642 placebo + AG Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer NCT07262567Phase 31 site๐Ÿ“ Beijing Genfleet Therapeutics (Shanghai) Inc. ยท Tests: GFH375, Chemotherapy Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604Phase 31 site๐Ÿ“ Gothenburg Sahlgrenska University Hospital ยท Tests: FOLFIRINOX or gemcitabine-nab-paclitaxel, FOLFIRINOX or gemcitabine-nab-paclitaxel Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery NCT07632118Phase 31 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Radiotherapy + GX, GX group A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer NCT06953999Phase 33 sites๐Ÿ“ Harbin๐Ÿ“ Shanghai๐Ÿ“ Hangzhou Akeso ยท Tests: Ivonescimab, AK117, Albumin-bound Paclitaxel, Gemcitabine, Ivonescimab, AK117 Placebo, Albumin-bound Paclitaxel, Gemcitโ€ฆ Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. NCT06897644Phase 328 sites๐Ÿ“ Aviano๐Ÿ“ Bari๐Ÿ“ Brescia Gruppo Oncologico del Nord-Ovest ยท Tests: Oxaliplatin, Irinotecan (CPT-11), Leucovorin, 5-FU (5-fluorouracil), gemcitabine Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene NCT05372614Phase 118 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Irvine National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Multigated Acquisition Scan Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma NCT07189195Phase 11 site๐Ÿ“ Sacramento University of California, Davis ยท Tests: TR-002 A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy NCT07651358NA1 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Physical Activity and Nutritional Recommendations and Support Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer NCT06423326Phase 22 sites๐Ÿ“ Washington D.C.๐Ÿ“ Atlanta Georgetown University ยท Tests: Biopsy, Biospecimen Collection, Cisplatin, Computed Tomography, Gemcitabine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy